Selective Mutism Clinical Trials
2 recruiting trials for Selective Mutism. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Selective Mutism clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Luuk Stapersma (1), Bradley Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is 'Speaking at school, a matter of doing' combined with VR homework exercises (behavioral, 1 trial), followed by Team-delivered, exposure-based CBT.
Track Selective Mutism trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
VR Homework Exercises for Selective Mutism Treatment
Selective mustism (SM) is an anxiety disorder that manifests in childhood. Children with Children with SM do not speak in certain social situations where this is expected of them....
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
The purpose of this study is to test how the delivery of Cognitive Behavioral Therapy (CBT) for pediatric anxiety and OCD via different methods might increase its availability and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Selective Mutism, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Selective Mutism, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Selective Mutism, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.